Cargando…
1510. Improving the Management of Pediatric Complicated Pneumonia
BACKGROUND: Pneumonia is a leading cause of pediatric hospitalization in the United States. Our Antimicrobial Stewardship Program (ASP) recognized significant variation in the management of pediatric complicated pneumonia. We developed and implemented a quality improvement (QI) intervention to align...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810427/ http://dx.doi.org/10.1093/ofid/ofz360.1374 |
_version_ | 1783462252476628992 |
---|---|
author | Nuibe, Andrew M Tran, Van Levorson, Rebecca E |
author_facet | Nuibe, Andrew M Tran, Van Levorson, Rebecca E |
author_sort | Nuibe, Andrew M |
collection | PubMed |
description | BACKGROUND: Pneumonia is a leading cause of pediatric hospitalization in the United States. Our Antimicrobial Stewardship Program (ASP) recognized significant variation in the management of pediatric complicated pneumonia. We developed and implemented a quality improvement (QI) intervention to align the management of complicated pneumonia with national guidelines and compared the medical care and clinical outcomes between a pre-intervention period and two post-intervention periods. METHODS: We queried Webi Universe for all ICD-9 and ICD-10-related admissions for pneumonia at our facility from November 15, 2015 to February 28, 2019. Manual chart review was done to extract clinical points of interest and to ensure that all included patients met inclusion criteria. Our first intervention (period 1) consisted of education to providers to increase use of chest tubes instilled with fibrinolytics and to decrease empiric antistaphylococcal therapy. Our second intervention (period 2) consisted of a care process model which codified the standardized management made by the first intervention, followed by several didactic sessions. RESULTS: 29 patients were identified in the pre-intervention period, 11 in post-intervention period 1, and 27 in post-intervention period 2. Streptococcal species were the most common pathogens recovered in all periods. Following our interventions the number of video-assisted thorascopic procedures to drain complicated parapneumonic effusions decreased three-fold in favor of chest tubes instilled with fibrinolytics (P < 0.01). Our interventions also reduced empiric antistaphylococcal therapy within the first 48 hours of admission (P = 0.02) and decreased the use of empiric vancomycin three-fold (P = 0.01). Our interventions did not affect the median length of stay, frequency of pulmonary complications, number of 30-day readmissions, or duration of antimicrobial therapy. CONCLUSION: Our ASP’s QI intervention decreased surgical drainage of complicated parapneumonic effusions and decreased the use of empiric antistaphylococcal agents without an increase in complications or readmissions. Opportunities remain to decrease the use of multiple antimicrobial agents within the first 48 hours of admission and to decrease the empiric use of antistaphylococcal therapy. DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-6810427 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-68104272019-10-28 1510. Improving the Management of Pediatric Complicated Pneumonia Nuibe, Andrew M Tran, Van Levorson, Rebecca E Open Forum Infect Dis Abstracts BACKGROUND: Pneumonia is a leading cause of pediatric hospitalization in the United States. Our Antimicrobial Stewardship Program (ASP) recognized significant variation in the management of pediatric complicated pneumonia. We developed and implemented a quality improvement (QI) intervention to align the management of complicated pneumonia with national guidelines and compared the medical care and clinical outcomes between a pre-intervention period and two post-intervention periods. METHODS: We queried Webi Universe for all ICD-9 and ICD-10-related admissions for pneumonia at our facility from November 15, 2015 to February 28, 2019. Manual chart review was done to extract clinical points of interest and to ensure that all included patients met inclusion criteria. Our first intervention (period 1) consisted of education to providers to increase use of chest tubes instilled with fibrinolytics and to decrease empiric antistaphylococcal therapy. Our second intervention (period 2) consisted of a care process model which codified the standardized management made by the first intervention, followed by several didactic sessions. RESULTS: 29 patients were identified in the pre-intervention period, 11 in post-intervention period 1, and 27 in post-intervention period 2. Streptococcal species were the most common pathogens recovered in all periods. Following our interventions the number of video-assisted thorascopic procedures to drain complicated parapneumonic effusions decreased three-fold in favor of chest tubes instilled with fibrinolytics (P < 0.01). Our interventions also reduced empiric antistaphylococcal therapy within the first 48 hours of admission (P = 0.02) and decreased the use of empiric vancomycin three-fold (P = 0.01). Our interventions did not affect the median length of stay, frequency of pulmonary complications, number of 30-day readmissions, or duration of antimicrobial therapy. CONCLUSION: Our ASP’s QI intervention decreased surgical drainage of complicated parapneumonic effusions and decreased the use of empiric antistaphylococcal agents without an increase in complications or readmissions. Opportunities remain to decrease the use of multiple antimicrobial agents within the first 48 hours of admission and to decrease the empiric use of antistaphylococcal therapy. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6810427/ http://dx.doi.org/10.1093/ofid/ofz360.1374 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Nuibe, Andrew M Tran, Van Levorson, Rebecca E 1510. Improving the Management of Pediatric Complicated Pneumonia |
title | 1510. Improving the Management of Pediatric Complicated Pneumonia |
title_full | 1510. Improving the Management of Pediatric Complicated Pneumonia |
title_fullStr | 1510. Improving the Management of Pediatric Complicated Pneumonia |
title_full_unstemmed | 1510. Improving the Management of Pediatric Complicated Pneumonia |
title_short | 1510. Improving the Management of Pediatric Complicated Pneumonia |
title_sort | 1510. improving the management of pediatric complicated pneumonia |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810427/ http://dx.doi.org/10.1093/ofid/ofz360.1374 |
work_keys_str_mv | AT nuibeandrewm 1510improvingthemanagementofpediatriccomplicatedpneumonia AT tranvan 1510improvingthemanagementofpediatriccomplicatedpneumonia AT levorsonrebeccae 1510improvingthemanagementofpediatriccomplicatedpneumonia |